# Kuanping Capital

> Kuanping Capital is a VC fund in Hangzhou backing Medical and Big Data. See 2 investments, check sizes, portfolio and contact details. Updated Sep 2026.

- Type: VC Fund
- Location: Hangzhou, China
- Total investments: 2
- Last investment: Apr 2021
- Lead investor: 50%
- Last updated: Sep 2026
- Website: http://kuanping-capital.com/

Kuanping Capital is an investment firm focusing on the health care sector. It is guided by research focused on key areas to visit enterprises one by one and explore the sub-domain investment logic. The firm actively participates in the management of invested companies. It provides strong support in strategic planning, mergers and acquisitions,listing, and financing.

## Contacts

5 contacts available for Kuanping Capital. Shizune tracks 1 team members at Kuanping Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/kuanping-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 100% |
| Big Data | 1 | 50% |
| InsurTech | 1 | 50% |
| Insurance | 1 | 50% |
| Health Care | 1 | 50% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Angel | 1 | 50% |
| Series B | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Lily Feng | Senior Investment Analyst | 0 | https://shizune.co/investors/profile/lily-feng |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Brattea | Brattea is a medical device research and development company. Brattea focuses on the development and commercialization of renal denervation products with indications in hypertension, cancer pain and diabetes. | $20M | Series B | Apr 06, 2021 |  |
| Nuanwa Technology | Nuanwa Technology is a health insurance technology platform. The company is positioned in the field of health insurance technology, mainly serving insurance companies and Internet platforms, providing products customization services, risk control, claims services, system services and other solutions for its health insurance business. Medicalecology and health insurance, open up barriers to medical data information. | $14M | Angel | Aug 29, 2019 |  |

2 of 2 investments shown.

## Co-investors
- [BioTrack Capital](https://shizune.co/investors/profile/biotrack-capital) — VC Fund, 1 deal together
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 1 deal together
- Brosmed — VC Fund, 1 deal together
- [Hengxu Capital](https://shizune.co/investors/profile/hengxu-capital) — VC Fund, 1 deal together
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund, 1 deal together
- [Northern Light Venture Capital](https://shizune.co/investors/profile/northern-light-venture-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [MS&AD Ventures](https://shizune.co/investors/profile/ms-ad-ventures) — VC Fund
- [Anthemis](https://shizune.co/investors/profile/anthemis-group) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

### Similar stage
- [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund
- [LVX Ventures](https://shizune.co/investors/profile/letsventure) — VC Fund
- [IAN Group](https://shizune.co/investors/profile/indian-angel-network) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund
- [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund

## Featured in investor lists
- [InsurTech Investors in China](https://shizune.co/investors/insurtech-investors-china)
- [InsurTech VC Funds in China](https://shizune.co/investors/insurtech-vc-funds-china)

## FAQ

### What does Kuanping Capital invest in?

Kuanping Capital invests primarily in Medical, Big Data and InsurTech startups, most often at Angel and Series B stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Kuanping Capital?

Public channels for Kuanping Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Kuanping Capital?

The team at Kuanping Capital includes Lily Feng (Senior Investment Analyst). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co